SCHEMBL16410684

SCHEMBL16410684

CCC1(CC)C(N=NCc2ccc(C(O)(CN=[N+]=[N-])CN=[N+]=[N-])cc2)=Nc2ccccc2N1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410849 0.80 — —
SCHEMBL16410696 0.68 — —
SCHEMBL16410743 0.62 — —
SCHEMBL16410698 0.58 ACAT2 (0.31) —
SCHEMBL28310918 0.58 CYP2C19 (0.38) —
SCHEMBL16410823 0.57 AMPD2 (0.34) —
SCHEMBL16410588 0.55 HSD11B1 (0.34) —
SCHEMBL13460530 0.52 CYP2C19 (0.39) —
SCHEMBL17927203 0.52 CYP2C19 (0.39) —
SCHEMBL14416069 0.52 CYP11B1 (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback